Live feed
Filing
SC 13G
SC 13G0001095449-19-000008·Correvio Pharma Corp.
Schedule 13G ownership disclosure
CORREVIO PHARMA CORP
Security class unavailable · CUSIP: 22026V105
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,125,000
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001095449-19-000008
- Form type
- SC 13G
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- Feb 15, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership